Fundz

Basking Biosciences, Inc. reported raising $55 Million in an initial SEC Form D filing, from an offering of $7 Million

PRIVATESep 10, 2020

Amount Raised

$55 Million

$55 Million sold, per SEC Form D (first sale Sep 10, 2020)

Round Type

Seed

Research Triangle ParkBiotechnology

Quick answer

Basking Biosciences raised $55 Million in a Seed round, dated September 10, 2020. Basking Biosciences is based in Research Triangle Park, North Carolina, United States.

How much did Basking Biosciences raise?
Basking Biosciences raised $55 Million in a Seed round on September 10, 2020.
What does Basking Biosciences do?
Basking is developing the first in class agent (BB-031) targeting von Willebrand Factor (VWF) along with a direct acting reversal agent (BB-025) to immediately the pharmacological effect of BB-031 in the event of..
Where is Basking Biosciences based and how big is it?
Basking Biosciences is based in Research Triangle Park, North Carolina, United States.
Who are the decision-makers at Basking Biosciences?
Fundz holds 1 contact at Basking Biosciences, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Basking Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • LIVER CO INC raised $200 (Pre-Seed) on October 23, 2020.
  • Wasatch Microfluidics, Inc. raised $6M on October 23, 2020.
  • Rezolute raised $41M on October 22, 2020.
  • Waveclear raised $625K on October 22, 2020.
  • Be Biopharma raised $52M (Series A) on October 22, 2020.
  • Halia Therapeutics raised $6.3M on October 22, 2020.

Who to call at Basking Biosciences, and when

A new round usually means Basking Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Basking Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Basking Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Basking Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Basking Biosciences

Location

964 High House Rd #3268

Research Triangle Park, North Carolina, United States

About

Basking is developing the first in class agent (BB-031) targeting von Willebrand Factor (VWF) along with a direct acting reversal agent (BB-025) to immediately the pharmacological effect of BB-031 in the event of bleeding. BB-031 is an RNA aptamer optimized for rapid onset of action and short duration of effect. Basking will initiate a Phase 2 trial in acute ischemic stroke in late 2023 and is exploring further application in pulmonary embolism in preclinical studies. The technology is based on two decades of translational research on RNA aptamers as therapeutic agents for cardiovascular diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Basking Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRich S., Executive Officer, Director, Promoter hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Basking Biosciences's next move

See what Strategic adds

Basking Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.